Pfizer UK chief hails 'incredible moment for science' as vaccine approved for use

The transcript discusses Pfizer and Biontech's milestone in developing a COVID-19 vaccine, highlighting its significance for society. It covers the vaccine's development, approval by the MHRA, and the distribution plan, including the delivery of doses to the UK. The global strategy for equitable vaccine distribution is emphasized, along with the importance of science in overcoming the pandemic. Storage conditions for the vaccine are also detailed.

What was the primary focus of Pfizer and BioNTech's plans in developing the COVID-19 vaccine?

• To develop a vaccine that only targets specific populations

• To create a vaccine that is both safe and effective in a timely manner

• To ensure the vaccine is the most expensive on the market

• To produce a vaccine as quickly as possible, regardless of safety

Where is the initial shipment of Pfizer and BioNTech's vaccine being delivered from?

• Germany

• France

• Belgium

• Netherlands

How many doses has the UK government committed to receiving from Pfizer and BioNTech?

• 50 million doses

• 30 million doses

• 20 million doses

• 40 million doses

What is a key consideration in the global distribution of the COVID-19 vaccine?

• Ensuring the vaccine is only available in wealthy countries

• Prioritizing countries with the highest population

• Focusing on countries with the lowest COVID-19 cases

• Ensuring equity in vaccine distribution across all countries

For how many days can the Pfizer and BioNTech vaccine be stored under normal refrigerated conditions?

• Ten days

• Seven days

• Five days

• Three days